Loading organizations...
Key people at BGN Technologies.
BGN Technologies is the technology transfer company of Ben-Gurion University of the Negev, responsible for commercializing academic research, managing intellectual property, and facilitating industry partnerships from its headquarters in Be'er Sheva, Israel. The organization manages a portfolio of hundreds of registered patents and operates with an estimated 205 employees, generating annual revenues of approximately $448 million through licensing fees, royalties, and equity stakes. Operating across sectors such as cybersecurity, artificial intelligence, biotechnology, and agritech, the firm has established over 100 spin-off startups and executes dozens of sponsored research agreements annually, including 125 deals signed in 2019 alone. To advance its commercialization efforts and support early-stage ventures through programs like the Oazis accelerator, the entity collaborates with multinational corporate partners and investors, including Deutsche Telekom, Lockheed Martin, IBM, Bayer, and OurCrowd. BGN Technologies was founded in 1968.
Key people at BGN Technologies.
BGN Technologies is the technology transfer company of Ben-Gurion University of the Negev (BGU), based in Beer-Sheva, Israel, within the Advanced Technologies Park.[1][3][4] It commercializes university inventions by incubating startups, forging industry partnerships, and bridging academia with global businesses, particularly to build a high-tech ecosystem in the Negev desert region.[1][2][3] Over the past six years, it has tripled patent applications, signed hundreds of industry agreements, and launched over 25 startups, emphasizing speed to market, flexibility, and long-term collaborations in areas like biotechnology, neurotechnology, and security.[1][2][3]
As a wholly owned BGU subsidiary, BGN serves multinational firms like Deutsche Telekom by providing access to early-stage research, solving process challenges, and creating sustainable innovation pipelines.[2][3] It acts as a single point of contact for researchers and industry, led by business experts, and holds 9 patents, including granted ones in neurotechnology for therapy prediction.[1][3]
BGN Technologies emerged as the dedicated arm of Ben-Gurion University, Israel's fastest-growing and most dynamic institution, located in Beer-Sheva to realize the vision of developing the Negev desert into a tech hub.[2][4] While exact founding details are not specified, its evolution ties to BGU's growth, with a surge in activity over the last six years: patent applications tripled, industry deals multiplied, and over 25 startups were spun out from university labs.[2]
Key figures include Chairman Gil Weiser, with a high-tech career as CEO of HP Israel, Digital Corp. Israel, and others, plus board roles at the Israel Stock Exchange; and Director-General Tal Ben Haim, formerly at Ernst & Young, bringing strategic planning expertise.[3] Pivotal moments include establishing Deutsche Telekom Labs in Beer-Sheva and global R&D frameworks, alongside a U.S. biotechnology center, marking BGN's shift to institutional partnerships.[2]
BGN rides the wave of industry-academia collaboration in Israel’s “Startup Nation,” channeling Negev-based research into global markets amid rising demand for deep-tech innovations like AI-driven neurotherapy and biotech.[1][2] Timing aligns with post-pandemic emphasis on R&D pipelines, where universities like BGU—fastest-growing in Israel—supply competitive edges through patents and startups, countering talent shortages for multinationals.[2][3]
Market forces favor BGN: Israel’s security tech prowess, biotech boom (e.g., U.S. center), and desert innovation hubs draw investors, while partnerships like Deutsche Telekom’s expand to usability/security projects.[2][6] It influences the ecosystem by spinning out 25+ companies, tripling IP output, and proving academia can deliver market-ready solutions, boosting the Negev as a rival to Tel Aviv’s tech scene.[2]
BGN is poised to scale its Negev ecosystem amid global deep-tech demand, potentially doubling startups and patents as AI, biotech, and security trends accelerate.[1][2] Expect deeper ties with multinationals, U.S./European expansions, and policy support for regional innovation, evolving from transfer agent to full-fledged venture builder. This positions BGN to sustain BGU's dynamic growth, turning desert labs into enduring global tech powerhouses.[2][3]
